Bone Metastasis

  • Mirna Abboud
  • Arnold C. Paulino
  • B. S. Teh
  • Simon S. Lo
  • Rex Marco
Part of the Medical Radiology book series (MEDRAD)


Bone is a common metastatic site for many types of solid cancers, especially those arising in the lung, breast and prostate. Around 80 % of patients with solid tumors develop painful bone metastases to the spine, pelvis, and extremities during the course of their disease (Nielson et al., Radiotheraphy Oncology 52:95, 1999). Multiple treatment options are available to treat bone metastases, including surgical fixation, bisphosphonates, chemotherapy and hormonal therapy, systemic radionuclides, hemibody irradiation, external beam radiation therapy and more recently stereotactic body radiation therapy (SBRT). Here we describe the effectiveness of SBRT in the management of bone metastases, its technical aspects, clinical applications and treatment toxicities. Clinical case examples will be included with the treatment plan, isodose lines and dose-volume histograms. We conclude with future directions in the use of SBRT for bone metastases.


Renal Cell Carcinoma Bone Metastasis External Beam Radiation Therapy Stereotactic Body Radiation Therapy Gross Tumor Volume 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. Agarawal J, Swangsilpa T, van der Linden Y et al (2006) The role of external beam radiotherapy in the management of bone metastases. Clinical Oncology 18:747–760PubMedCrossRefGoogle Scholar
  2. Ben-Josef E, Shamsa F, Williams AO, Porter AT (1998) Radiotherapeutic management of osseous metastases: a survey of current patterns of care. Int J Radiat Oncol Biol Phys 40:915PubMedCrossRefGoogle Scholar
  3. Boyle WJ, Simonet WS, Lacey DL (2003) Osteoclast differentiation and activation. Nature 423:337–342PubMedCrossRefGoogle Scholar
  4. Buchali K, Correns HJ, Schuerer M et al (1988) Results of a double blind study of 89-strontium therapy of skeletal metastases of prostatic carcinoma. Eur J Nucl Med 14:349–351PubMedCrossRefGoogle Scholar
  5. Chow E, Danjoux C, Wong R et al (2000) Palliation of bone metastases: a survey of patterns of practice among Canadian radiation oncologists. Radiother Oncol 56:305PubMedCrossRefGoogle Scholar
  6. Chow E, Hoskin PJ, Wu J, Roos D, van der Linden Y, Hartsell W, Vieth R, Wilson C, Pater J (2006) A phase III international randomised trial comparing single with multiple fractions for re-irradiation of painful bone metastases: National Cancer Institute of Canada Clinical Trials Group (NCIC CTG) SC 20. Clin Oncol (R Coll Radiol) 18:125CrossRefGoogle Scholar
  7. Chow E, Harris K, Fan G et al (2007) Palliative radiotherapy trials for one metastases: A systematic review. J Clin Oncol 25:1423–1436PubMedCrossRefGoogle Scholar
  8. Coleman RE. (2006) Clinical Features of Metastatic Bone Disease and Risk of Skeletal Morbidity. Clin Cancer Res 12(20S):S6243–S6249CrossRefGoogle Scholar
  9. DiBiase SJ, Valicenti RK, Schultz D, Xie Y, Gomella LG, Corn BW (1997) Palliative irradiation for focally symptomatic metastatic renal cell carcinoma: Support for dose escalation based on a biological model. J Urol 158(3Pt 1):746–749PubMedGoogle Scholar
  10. Doh LS, Amato RJ, Paulino AC, Teh BS (2006) Radiation therapy in the management of brain metastases from renal cell carcinoma. Oncol (Williston Park) 20(6):603–613; discussion 613, 616, 619–620 passsimGoogle Scholar
  11. Doung YC, Kenan S, Rapp T (2011) Metastatic lesions of the proximal femur. Bull NYU Hosp Jt Dis. 69(1):81–86PubMedGoogle Scholar
  12. Firusian N, Mellin P, Schmidt CG (1976) Results of 89 strontium therapy in patients with carcinoma of the prostate and incurable pain from bone metastases: A preliminary report. J Urol 116:764–768PubMedGoogle Scholar
  13. Gerszten PC, Ozhasoglu C, Burton SA, Welch WC, Vogel WJ, Atkins BA, Kalnicki S (2003) CyberKnife frameless single-fraction stereotactic radiosurgery for tumors of the sacrum. Neurosurg Focus 15(2):E7PubMedCrossRefGoogle Scholar
  14. Gerszten P, Burton S, Ozhasoglu C et al (2005) Stereotactic radiosurgery for spinal metastases from renal cell carcinoma. JNeurosurg Spine 3:288-295CrossRefGoogle Scholar
  15. Gibbs IC, Chang SD (2003) Radiosurgery and radiotherapy for sacral tumors. Neurosurg Focus 15(2):E8PubMedCrossRefGoogle Scholar
  16. Greenberg H, Kim J, Posner J (1980) Epidural spinal cord compression from metastatic tumor: results of a new treatment protocol. Ann Neurol 8:361–366PubMedCrossRefGoogle Scholar
  17. Hartsell WF, Scott CB, Bruner DW, Scarantino CW, Ivker RA, Roach M 3rd, Suh JH, Demas WF, Movsas B, Petersen IA, Konski AA, Cleeland CS, Janjan NA, DeSilvio M (2005) Randomized trial of short- versus long-course radiotherapy for palliation of painful bone metastases. J Natl Cancer Inst 97(11):798–804PubMedCrossRefGoogle Scholar
  18. Hatoum HT, Lin SJ, Smith MR et al (2008) Zoledronic acid and skeletal complications in patients with solid tumors and bone metastases. Cancer 113(6):1438–1445PubMedCrossRefGoogle Scholar
  19. Hoshi S, Jokura H, Nakamura H, Shintaku I, Ohyama C, Satoh M, Saito S, Fukuzaki A, Orikasa S, Yoshimoto T (2002) Gamma-knife radiosurgery for brain metastasis of renal cell carcinoma: Results in 42 patients. Int J Urol 9(11):618–625; discussion 626; author reply 627PubMedCrossRefGoogle Scholar
  20. Hoskin PJ, Stratford MR, Folkes LK, Regan J, Yarnold JR (2000) Effect of local radiotherapy for bone pain on urinary markers of osteoclast activity. Lancet 355:1428–1429PubMedCrossRefGoogle Scholar
  21. Huguenin PU, Kieser S, Glanzmann C, et al (1998) Radiotherapy for metastatic carcinomas of the kidney or melanomas: An analysis using palliative end points. Int J Radiat Oncol Biol Phys 41(2):401–405PubMedCrossRefGoogle Scholar
  22. Jhaveri P, Teh BS, Bloch C, Amato R, Butler EB, Paulino AC (2008) Stereotactic body radiotherapy in the management of painful bone metastases. Oncol(Williston Park) 22(7):782–788; discussion 788–789, 796–787Google Scholar
  23. Jhaveri P, Teh B, Paulino A, Blanco A, Lo S, Butler EB, Amato R (2012) A Dose-response relationship for time to bone pain resolution after stereotactic body radiotherapy (SBRT) for renal cell carcinoma bony metastases. Acta Oncol J 51(5):584–588CrossRefGoogle Scholar
  24. Kirou-Mauro A, Hird A, Wong J, Sinclair E, Barnes EA, Tsao M, Danjoux C, Chow E (2008) Is response to radiotherapy in patients related to the severity of pretreatment pain? Int J Radiat Oncol Biol Phys 71:1208PubMedCrossRefGoogle Scholar
  25. Lutz S, Berk L, Chang E et al (2011) Palliative radiotherapy for bone metastases: An ASTRO evidence-based guideline. Int J Radiat Oncol Biol Phys 79:965PubMedCrossRefGoogle Scholar
  26. Milker-Zabel S, Zabel A, Thilmann C et al (2003) Clinical results of retreatment of vertebral bone metastases by stereotactic conformal radiotherapy and intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys 55:162–167PubMedCrossRefGoogle Scholar
  27. Nguyen QN, Shiu AS, Rhines LD, Wang H, Allen PK, Wang XS, Chang EL (2010) Management of spinal metastases from renal cell carcinoma using stereotactic body radiotherapy. Int J Radiat Oncol Biol Phys 76(4):1185–1192PubMedCrossRefGoogle Scholar
  28. Nielsen OS (1999) Palliative radiotherapy of bone metastases: there is now evidence for the use of single fractions. Radiother Oncol 52:95PubMedCrossRefGoogle Scholar
  29. Noel G, Valery CA, Boisserie G, Cornu P, Hasboun D (2004) Marc Simon J, Tep B, Ledu D, Delattre JY, Marsault C, Baillet F, Mazeron JJ. Linac radiosurgery for brain metastasis of renal cell carcinoma. Urol Oncol 22(1):25–31PubMedCrossRefGoogle Scholar
  30. Oosterhof GO, Roberts JT, de Reijke TM, et al (2003) Strontium(89) chloride versus palliative local field radiotherapy in patients with hormonal escaped prostate cancer: A phase III study of the European Organisation for Research and Treatment of Cancer, Genitourinary Group. Eur Urol 44:519–526Google Scholar
  31. Pavlakis N, Schmidt RL, Stockler M (2005) Bisphosphonates for breast cancer. Cochrane Database Syst Rev. 20;(3):CD003474Google Scholar
  32. Quilty PM, Kirk D, Bolger JJ et al (1994) A comparison of the palliative effects of strontium-89 and external beam radiotherapy in metastatic prostate cancer. Radiother Oncol 31:33–40PubMedCrossRefGoogle Scholar
  33. Reddy EK, Robinson RG, Mansfield CM (1986) Strontium 89 for palliation of bone metastases. J Natl Med Assoc 78:27–32PubMedGoogle Scholar
  34. Roqué i Figuls M, Martinez-Zapata MJ, Scott-Brown M, Alonso-Coello P (2011) Radioisotopes for metastatic bone pain. Cochrane Database Syst Rev 6;(7):CD003347Google Scholar
  35. Rosen LS, Gordon D, Tchekmedyian NS et al (2004) Long-term efficacy and safety of zoledronic acid in the treatment of skeletal metastases in patients with nonsmall cell lung carcinoma and other solid tumors. Cancer 100(12):2613–2621PubMedCrossRefGoogle Scholar
  36. Salazar OM, Sandhu T, da Motta NW et al (2001) Fractionated half-body irradiation (HBI) for the rapid palliation of widespread, symptomatic, metastatic bone disease: a randomized Phase III trial of the International Atomic Energy Agency (IAEA). Int J Radiat Oncol Biol Phys 50:765PubMedCrossRefGoogle Scholar
  37. Schefter TE, Kavanagh BD, Timmerman RD et al (2005) A phase I trial of stereotactic body radiation therapy (SBRT) for liver metastases. Int J Radiat Oncol Biol Phys 62(5):1371–1378PubMedCrossRefGoogle Scholar
  38. Sheehan JP, Sun MH, Kondziolka D, Flickinger J, Lunsford LD (2003) Radiosurgery in patients with renal cell carcinoma metastasis to the brain: Long-term outcomes and prognostic factors influencing survival and local tumor control. J Neurosurg 98(2):342–349PubMedCrossRefGoogle Scholar
  39. Smeland S, Erikstein B, Aas M et al (2003) Role of strontium-89 as adjuvant to palliative external beam radiotherapy is questionable: Results of a double-blind randomized study. Int J Radiat Oncol Biol Phys 56:1397–1404PubMedCrossRefGoogle Scholar
  40. Sze WM, Shelley M, Held I, et al (2003) Palliation of metastatic bone pain: Single fraction versus multifraction radiotherapy: A systemic review of randomized trials. Clin Oncol 15:345–352, Wedin R, Hansen BH, Laitinen M, Trovik C, Timmerman RD et al A Phase II Trial of Stereotactic Body Radiation Therapy (SBRT) in the treatment of patients with medically inoperable stage I/II non-small cell lung cancer. radiation therapy oncology Group; RTOG 0236Google Scholar
  41. Teh BS, Bloch C, Galli-Guevara M, Doh L, Richardson S, Chiang S, Yeh P, Gonzalez M, Lunn W, Marco R, Jac J, Paulino AC, Lu HH, Butler EB, Amato RJ (2007a) The treatment of primary and metastatic renal cell carcinoma (RCC) with image-guided stereotactic body radiation therapy (SBRT). Biomed Imaging Interv J 3(1):e6PubMedGoogle Scholar
  42. Teh BS, Bloch CB, Paulino AC, Shen S, Hinckley L, Baskin D, Butler EB, Amato RJ (2007b) Pathological complete response in renal cell carcinoma brain metastases treated with stereotactic radiosurgery. Clin Genitourin Cancer 5(5):334–337PubMedCrossRefGoogle Scholar
  43. Teh BS, Paulino AC, Lu HH, Chiu JK, Richardson S, Chiang S, Amato R, Butler EB, Bloch C (2007c) Versatility of the Novalis system to deliver image-guided stereotactic body radiation therapy (SBRT) for various anatomical sites. Technol Cancer Res Treat 6(4):347–354PubMedGoogle Scholar
  44. Walsh L, Stanfield JL, Cho LC, Chang CH, Forster K, Kabbani W, Cadeddu JA, Hsieh JT, Choy H, Timmerman R, Lotan Y (2006) Efficacy of ablative high-dose-per-fraction radiation for implanted human renal cell cancer in a nude mouse model. Eur Urol 50(4):795–800; discussion 800, Google Scholar
  45. Wedin R, Hansen BH, Laitinen M, Trovik C, Timmerman RD et al (2011) A Phase II Trial of Stereotactic Body Radiation Therapy (SBRT) in the Treatment of Patients with Medically Inoperable Stage I/II Non-Small Cell Lung Cancer. Radiation Therapy Oncology Group; RTOG 0236Google Scholar
  46. Wu JS, Wong R, Johnston M et al (2003) Meta-analysis of dose-fractionation radiotherapy trials for the palliation of painful bone metastases. Int J Radiat Oncol Biol Phys 55:594–605PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2012

Authors and Affiliations

  • Mirna Abboud
    • 1
  • Arnold C. Paulino
    • 1
  • B. S. Teh
    • 1
  • Simon S. Lo
    • 2
  • Rex Marco
    • 3
  1. 1.Department of Radiation OncologyThe Methodist Hospital, Cancer Center and Research InstituteHoustonUSA
  2. 2.Department of Radiation OncologyUniversity Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center, Case Western Reserve UniversityClevelandUSA
  3. 3.Department of Orthopaedic SurgeryUniversity of Texas Health Science CenterHoustonUSA

Personalised recommendations